巨子 ICON - 財經股票資訊及專家分析
搜尋 股票

CohBar

CWBR
最少15分鐘延遲,股票資訊由第三方資訊供應商提供
・CohBar - 延遲價格・最後更新於 14/01 12:14
最高位
0.370
最低位
0.351
開市價
--
前收市價
0.370
成交量(千)
20.89
成交額(百萬)
0.06
買入
--
賣出
--
每手股數
--
市值(百萬)
31.41
市盈率
--
息率
--
差價
--
52週高低
2.270 - 0.340
所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

企業資料

公司名稱
CohBar
證券代碼
CWBR.US
所屬板塊
Biotechnology
公司業務
CohBar Inc is a biotechnology company. It is engaged in the research and development of mitochondria based therapeutics (MBTs) to treat various diseases associated with aging and metabolic dysfunction. The product portfolio of the company includes drug such as CB4209 and CB4211, SHLP-6, SHLP-2 and new MBTs, these address a broad range of age-related diseases, including obesity, fatty liver disease, Type-2 diabetes, cancer, cardiovascular and neurodegenerative diseases. Geographically all the operation of the group is functioned through the region of United States.
發行量
61788325
公司總部
1455 Adams Drive, Suite 2050
公司網址
https://www.cohbar.com
公司電郵
Jordyn.tarazi@cohbar.com
公司電話
+1 650 446-7888
暫無內容

關於

CohBar(CWBR.US)所屬的行業板塊為Biotechnology。
CohBar Inc is a biotechnology company. It is engaged in the research and development of mitochondria based therapeutics (MBTs) to treat various diseases associated with aging and metabolic dysfunction. The product portfolio of the company includes drug such as CB4209 and CB4211, SHLP-6, SHLP-2 and new MBTs, these address a broad range of age-related diseases, including obesity, fatty liver disease, Type-2 diabetes, cancer, cardiovascular and neurodegenerative diseases. Geographically all the operation of the group is functioned through the region of United States.
詳細公司背景可參考: https://www.cohbar.com